Pharma Journalist

Microbiome Connect: Europe
2022-07-06 - 2022-07-07 | Amsterdam
The 8th Annual Microbiome Connect: Europe 2022 dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia, engineered microbes, and microbial-derived metabolites for therapeutic and health applications in patients and consumers.
As the first EMA approved microbiome-targeted therapeutics emerge on the horizon, drug developers will have to opportunity to benchmark their rational drug platforms, targeting validated pathways in gastrointestinal, neurological, metabolic disorders, as well as oncology-based indications.
Furthermore, there will be separate tracks dedicated to developing novel, clinical-validated product formulations for nutritional, digestive wellness, oral and skincare applications.
Join the microbiome field to hear from biotechs, pharma voices, investment bodies, consumer product brands and more, on how to develop robust, scalable, and reproducible formulations for microbe-derived/-targeting products entering late-stage investigations and reaching for the market.
To know more visit: https://hubs.ly/Q012R7H40

3rd Annual Gene Therapy for Neurological Disorders Europe
2022-07-11 - 2022-07-13 | Paris Marriott Charles de Gaulle Airport Hotel, Zone Hoteliere, 5 All. du Verger, Roissy-en-France, 95700
Accelerating Europe’s Progress in CNS Gene Therapy
Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic
As programs advance globally, the 3rd Annual Gene Therapy for Neurological Disorders Europe meeting is the industry’s definitive forum dedicated to showcasing the European landscape’s progress and specific regulatory challenges as they move from rare neurological disorders to targeting more common diseases including Parkinson’s, epilepsy and neurodevelopmental disorders.
Returning as its first in-person meeting, with brand new speakers and companies joining the conversation, attend alongside 100 fellow preclinical, translational, clinical and commercial gene therapy experts to overcome your translational challenges and improve the delivery of your gene therapy to its CNS target, and optimize your European strategy as you move from rare to common patient populations.
To know more visit: https://ter.li/l4b1t3

Digital Biomarkers and Clinical Measures in Neurology Summit
2022-07-11 - 2022-07-13 | The Bostonian, 26 North St, Boston, MA, 02109, United States
The Digital Biomarkers & Clinical Measures in Neurology Summit is the definitive industry forum sharing cross-industry insight to transform clinical development with digital data.
From integrating wearable technologies, smartphone apps, and speech-based digital biomarkers into remote clinical research to elucidating pathways to clinical validation to establish therapeutic efficacy, join industry experts from Merck, Janssen, GSK, Sanofi, Novartis, Takeda, Eli Lilly & Company, Mitsubishi Tanabe Pharma Holdings America and many more to improve patient retention and establish efficacy with richer datasets.
To know more visit: https://ter.li/mk4lmh

3rd GxP Cloud Compliance Summit
2022-07-12 - 2022-07-14 | The Bostonian, 26 North St, Boston, MA, 02109, United States
Migrate Your GxP Regulated Applications to the Cloud with Compliance, Security, & Quality Assurance
With hot anticipation for the FDA’s new CSA guidance, life science companies have the opportunity to take a proactive stance in their approach to the new methodologies. In the climate of this exciting new era of computer systems validation, join over 100 Life Science, IT & Quality professionals at the 3rd GxP Cloud Compliance Summit.
Emulating on 2021’s success, the 3rd GxP Cloud Compliance Summit is excited to return in July, for the first time in person!
This is your only opportunity to develop and implement a practical roadmap to migrate your GxP regulated applications to the cloud with real-life insights from regulatory, security and quality experts from leading life science companies, as well as cloud providers, auditors, and industry regulators.
With the FDA strongly advising life science organizations to start getting ready for CSA now, join us in July to discover how your business can get ahead and simplify the transition process.
To know more visit: https://ter.li/uichgz

BCMA Targeted Therapies Summit
2022-07-12 - 2022-07-14 | The Bostonian, 26 North St, Boston, MA, 02109, United States
With the undeniable excitement in the BCMA field over the past few months, the BCMA-Targeted Therapies Summit returns to the space to equip you with the knowledge and connections to revolutionize your BCMA-centered pipeline.
Pick the brains of 90+ academic and industry pioneers at the first physical edition of the only meeting dedicated to supercharging transformative next generation BCMA-targeted therapies into the clinic, navigating the complex landscape and optimizing clinical strategy to revolutionize treatment of multiple myeloma and beyond.
Hear from leading speakers including:

Suzette Girgis, Senior Director & Head of Clinical Pharmacology & Hematologic Malignancies, Johnson & Johnson Services
Eric Fedyk, Global Program Leader of BCMA Assets, 2seventy bio
David DiLillo, Director, Immuno-Oncology, Regeneron
Brandon Kremer, Group Senior Medical Director, Clinical Development Lead, GlaxoSmithKline
Nathan Martin, Translational Scientist & Project Lead, Bristol Myers Squibb
Mike Damore, Director & Lead – Translational Oncology, Pfizer
Chetasi Talati, Medical Director, AbbVie
Dexiu Bu, Senior Principle Scientist, CART group, Immuno-Oncology & Hematology, Novartis
Faiza Zafar, Senior Medical Science Liaison, Legend Biotech

Take a look at the full event guide to learn more.

Advanced Wound Care Summit
2022-07-13 - 2022-07-14 | Boston, MA (Venue TBD)
The Advanced Wound Care Innovation Summit is the first industry-led forum focused on delivering innovative wound care treatments to patients. Expect to hear from, and discuss with, world leaders of wound care research who are driving the development of novel biomaterials, remote-monitoring devices, and digital health management solutions.
Find out how C-level Executives, VPs and Directors of R&D are tackling the most pressing industry challenges and seizing new growth opportunities. Whether an executive, investor, researcher or healthcare professional, this meeting offers an empowering environment that allows you to make wound care decisions with confidence.
To know more visit: www.advancedwoundcareusa.com

RNA Therapeutic Modalities Summit USA
2022-07-15 - 2022-07-16 | Boston, USA
The RNA Therapeutic Modalities Summit is North America’s only industry led conference covering clinical progress and commercial scale development for the full spectrum of RNA therapeutic approaches.
Our agenda will featuring the pioneering biotechs translating current vaccine success into further clinically validated treatments in broader indications using RNA technologies such as antisense oligonucleotides, aptamers, small interfering RNAs (siRNAs), microRNAs, and messenger RNA (mRNA).
There will be dedicated discussion on the rationale for different mechanisms-of-action, how to optimise the power and versatility of RNA-based constructs, and the progress to date in disease indications encompassing neurodegeneration, metabolic and cardiovascular disorders and various cancers.
If your R&D teams are looking to establish a differentiated drug platform through RNA modification and delivery systems, improve stability, delivery and durability of current drug candidates, or enable tissue-specific administration with higher targeting ability and less toxicity, make sure they secure a place at this hotly anticipated conference. We look forward to welcoming you to Boston for dedicated in-person networking in June!
To know more visit: https://hubs.ly/Q012R75G0

2nd Annual Next Generation Gene Therapy Vectors Summit
2022-07-18 - 2022-07-20 | Hyatt Regency Boston, One Ave. de Lafayette, Boston, MA, 02111, United States
Overcome First Generation Gene Therapy Vector Challenges To Guarantee Targeted, Specific, Efficient & Safe Gene Delivery
The 2nd Next Generation Gene Therapy Vectors Summit is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors to deliver safe and efficacious gene therapy products.
Industry pioneers from cutting edge biopharma and world-leading academic vectorology groups are set to share clinically meaningful insights on how to enhance existing vectors and pioneer radical novel approaches to deliver genes more efficiently and safely.
Spanning a range of delivery approaches from cutting-edge AAV capsid optimization, utilizing lenti and other viral vectors, to innovative non-viral gene therapy approaches, this comprehensive event will enable you to reduce immunogenicity, improve tissue targeting, simplify manufacturing and enhance the safety profile of your approach.
Everything in gene therapy starts with delivery, so join this definitive, niche conference to delve into the details of vector design, engineering and optimization case studies, equipping you with the insights required to deliver transformative therapeutics to patients more effectively and safely than ever before.
To know more visit: https://ter.li/3mccj3

LEAP HR Life Sciences East
2022-07-18 - 2022-07-20 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
LEAP HR: Life Sciences East 2022 Conference will be taking place as an in-person event in Boston, July 18-20. Returning as a physical event for its seventh year, this event will showcase 35+ case studies of how life sciences organizations of all stages and sizes are redefining post-pandemic best practices and turbocharging the employee experience to meet the holistic and previously unmet needs of your in-demand life science workforce.
This is a unique chance to take advantage of a combination of plenary sessions, breakout sessions, panels and roundtable discussions specifically designed to solve your biggest HR challenges and deliver actionable insights for HR innovation.
Network with 250+ other strategic HR leaders working within life sciences on the East Coast and surrounding areas and join a support network of 500+ life science HR leaders who have previously taken part.
You’ll hear from companies such as: Takeda, Novo Nordisk, AstraZeneca, Pfizer, Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Alnylam Pharmaceuticals, BioNTech, Ipsen, Novartis, PTC Therapeutics, TCR2 Therapeutics, Ginkgo BioWorks and more…
Find out more by visiting the website: https://leap-hr-lifesciences-east.com/

Cell Therapy Potency Assay Summit
2022-07-25 - 2022-07-27 | The Bostonion, 26 North Street, Boston, MA, 02109, United States
Cell Therapy Potency Assay Summit, taking place from 25-27 of July in Boston, will bring together professionals working in analytical development, quality, regulatory and process development functions.
Join your peers to:

Brainstorm best-in-class approaches to overcome variability in QC
Compare next gen approaches from cytotoxicity to omics
Develop reference standards to benchmark across the industry
Create an assay with commercialization in mind.

This summit will equip you with the tools you need to fast track your regulatory submissions and ease through clinical development.
You can view the event guide here: https://ter.li/6a13vg
Secure your place at the summit here: https://ter.li/zp17ep
We are looking forward to welcoming you to Boston this July!

3rd Gamma Delta T Therapies Summit
2022-07-26 - 2022-07-28 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
The data has dropped and 2022 has been touted as a monumental year for γδT Therapies
With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on.
Join the 3rd Gamma Delta T Therapies Summit to learn and network with 120+ of the world’s leaders including γδT pioneer, Adrian Hayday, and together accelerate the development of effective, persistent, globally accessible cell therapy for solid tumors.
Take a look at the official program here.
Enhance cytotoxicity, discover novel targets, engineer stealth and persistence, interrogate cell subsets, and scale-up manufacturing through a deep understanding of the fundamental biology and target product profile for γδT therapies.
Industry experts agree that this year, the γδT is the cell to know. Ensure you and your team are ahead of the curve and equipped with the need-to-know insights to advance successful therapeutics, across 2 dedicated tracks covering Discovery, Process Research, Preclinical, and Clinical Development; as well as 3 deep-dive workshops, and a Gamma Delta 101 Bootcamp.

3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit
2022-07-26 - 2022-07-28 | The Bostonian, 26 North St, Boston, MA, 02109, United States
The 3rd Annual B & T Cell-Mediated Autoimmune Disease Drug Development Summit is the only industry-led forum focused on the therapeutic opportunity of drugs directed against B-cell, plasma cell, and T-cell targets in autoimmunity.

Several drug approvals for B-cell directed therapies have made waves in autoimmune drug development. As investment and industry momentum increases, this summit will once again unite the movers and shakers of the B&T cell-mediated autoimmune space with the likes of Pfizer, Nurix, Regeneron, Gossamer Bio, and more.
Take a look at the 2022 program here.
Attending this summit is a unique opportunity to be involved in interactive discussions on:

Overcoming challenges of heterogeneity of disease models and demonstrating B cell activation in tissues
Emerging therapies including B-cell specific therapies, tolerizing approaches, small molecule drugs, engineered cell immunotherapy, B&T cell checkpoint targeting, FcRn inhibition, as well as PROTAC/degrader approaches
Therapeutic opportunities across both peripheral and tissue specific autoimmune diseases
Overcoming clinical challenges of treating B&T cell mediated autoimmune diseases through combinatorial regimens that target T-cell co-stimulation, leveraging autoantibody signatures to identify patient responders and discussing autoimmune disease biomarkers

As the space grapples with translational and early clinical drug development challenges, join this comprehensive forum 80+ key leaders and decision-makers to harness the immune system and conquer B&T cell mediated autoimmune diseases.

Cytokine-Based Drug Development Summit
2022-07-26 - 2022-07-29 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field.
With 30+ expert speakers, including the hottest academic researchers and leading figures from the industry, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought provoking discussions around how to overcome the fields greatest drug development challenges.
What can you expect to see?

Further your understanding of the underlying mechanisms of action, and T-cell exclusion from the tumor in order to turn cold tumors ‘hot’ with Ask-Gene Pharma
Optimize cytokine engineering to ensure stability and improve the favorable risk benefit profile with Proviva Therapeutics
Leverage insights from industry’s leading lights to overcome toxicity challenges by ensuring tumor targeting is selective and therefore enhances the anti-tumor response with Equilium, Cytonus Therapeutics & Cytimmune
Take a deep dive into preclinical cancer models covering both in vitro and in-vivo studies and how these are unveiling the most favoured pharmaceuticals properties of therapeutic cytokines with Astra Zeneca & Xilio Therapeutics
Uncover the latest data coming out of the clinic of cytokines in combination with checkpoint inhibitors and monoclonal antibodies with Alkermes & NeoImmune Tech

Get your copy of the brand-new agenda for the full list of speakers and sessions.

2nd Annual mRNA-Based Therapeutics Summit
2022-07-26 - 2022-07-28 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Do you want to be part of the largest gathering of mRNA professionals?
The 2nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28.
Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content and 45+ deep-dive case studies. Find out more in the full event guide: https://ter.li/yc800m
Here’s a snapshot of the expert speakers you can hear from:

​​​​Kathy Fernando, VP, Head of Worldwide Research, Development and Medical Operations & Head of mRNA Scientific Planning, Pfizer
Regis Gervier, Global Head, mRNA Center of Excellence, Sanofi
Rituparna Das, VP – COVID Vaccines, Moderna
Hao Chen, Global Head of Cell & Viral Drug Substance, GlaxoSmithKline
Joe Payne, Founder, President & CEO, Arcturus Therapeutics
Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation
Manmohan Singh, SVP – Pharmaceutical Sciences & Delivery Technologies, Beam Therapeutics
Akhilesh Bhambhani, Senior Director – Biologics Drug Product Development; Tech Dev/Tech Ops, Ultragenyx
Liang Shang, Senior Scientist – Vaccine Analytical, Merck
Russell Johnson, VP – Formulation Research, RVAC Medicines
Tamar Grossman, Global Head – RNA & Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson

Download the official brochure to discover why Sanofi, Ultragenyx, Beam Therapeutics, Pfizer, Moderna, Merck, Eli Lilly, GSK, and 300+ others have already secured their places. https://ter.li/yc800m

iPSC Manufacturing Summit
2022-07-26 - 2022-07-28 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
With iPSCs exhibiting game-changing potential in the bid to develop an off-the-shelf therapy, the brand-new iPSC Manufacturing Summit is the only summit dedicated to solving the manufacturing, quality and analytical challenges hindering your iPSC-derived treatments from reaching patients.
This forum will unite the exclusive community advancing the production of high-quality and consistent iPSC products, with in depth case studies aimed to develop optimal differentiation, cryopreservation, and analytical protocol to enhance process development to ensure it is robust, rapid and repeatable.
Our 17+ expert speakers will be addressing methods to enhance potency testing and cell characterization, enhance iPSC product quality, and integrate successful gene-editing into your manufacturing.
Take a look at the full event guide to learn more.

Targeted Radiopharmaceuticals Summit US (TRP US)
2022-07-26 - 2022-07-28 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The brand-new Targeted Radiopharmaceuticals Summit US (TRP US) is the only industry-led meeting dedicated to developing next-generation radioligands. The TRP sector has developed dramatically over the previous 18 months, with a wave of new investment in light of Lutathera’s extraordinary performance.
Are you part of a pharmaceutical business aiming to have their Theranostic approved? If so, this agenda is designed to deliver you a well-rounded and complete understanding of the fast-paced radiopharmaceutical sector while also learning about the critical function of diagnostic imaging.
Hear the latest insights, case studies, and novel data to help accelerate the development of next-generation radioligand therapies from clinical approval to commercialization. This is the only in-person meeting to bring the discussion around the challenges and opportunities facing developers of Theranostic radioligand therapies.
To know more visit: https://ter.li/jtzz4q
